Primary Bone Marrow CD34+ Cells, Normal, Human from ATCC

Product Specs
ItemPrimary Bone Marrow CD34+ Cells, Normal, Human
CompanyATCC
Price $1,300.00Supplier Page View Company Product Page
Catalog NumberPCS-800-012
Quantity>= 5.0 x 10^5
TypeCell Biology
SpeciesHomo sapiens
TissueBone
Cell Type (standardized)CD34+ Cells
Tissue (standardized)Bone Marrow
ApplicationsApplications for use include the study of stem cell biology, hematology, transplantation, and oncology
Research Area3D cell culture, Immunology, Stem cell research, Toxicology, Immuno-oncology, Cell and gene therapy (CGT) development
Cell Typehematopoietic stem
GenderLot specific
Agelot-specific
Diseasenormal
Volume0.5 mL

Add to Compare List

ATCC

10801 University Boulevard

Manassas, Virginia 20110-2209

United States

Phone: (703) 365-2700
Fax: (703) 365-2701

Company Profile

Website: http://www.atcc.org

(1) Preclinical Pharmacokinetic, Pharmacodynamic, and Safety Profile of OBI-992: A Novel TROP2-Targeted Antibody–Drug ConjugateMolecular Cancer TherapeuticsDecember 2, 2025Chi-Sheng Shia, Shih-Ni Wen, Ren-Yu Hsu, Jyy-Shiuan Tu, Hui-Wen Chang, Hao-Cheng Weng, Jhih-Jie Yang, Ming-Feng Chiang, Yu-Hsuan Tsao, Chi-Huan Lu, et al.colleagues (31) Briefly, bone marrow–derived human CD34+ stem cells (RRID: CVCL_6F98; ATCC, catalog #: PCS-800-012) were expanded in SFEM II medium with CC100 supplement and then differentiated in a three-step procedure.

(2) Prognostic value of serum lipids in newly diagnosed acute promyelocytic leukemiaFrontiers in OncologyFebruary 18, 2025Shijie Wang, Qian Wang, Shuxin Lv, Ling Qin(ACC 207, DSMZ) and HL-60 (CCL-240™, ATCC) cell lines were chosen as models, while CD34+ cell line (PCS-800-012™, ATCC) was selected as a negative control. During culture, RPMI 1640 medium (Thermo Fisher Scientific,

(3) A conserved nutrient responsive axis mediates autophagic degradation of miRNA–mRNA hybrids in blood cell progenitorsNucleic Acids ResearchJanuary 11, 2024Sushmit Ghosh, Sreemoyee Chakraborti, Devki Devi, Rajesh Sahu, Sudip Mandal, Lolitika Mandalof human HSPC Primary Bone Marrow CD34+ Hematopoietic Cells, Normal, Human were acquired from ATCC (PCS-800-012). Hereafter, these CD34+ cells were cultured in IMDM media with 20% FBS. Before any treatment, these

(4) BiTE-Secreting CAR-γδT as a Dual Targeting Strategy for the Treatment of Solid TumorsAdvanced science (Weinheim, Baden-Wurttemberg, Germany)June 1, 2023Huang SW, Pan CM, Lin YC, Chen MC, Chen Y, Jan CI, Wu CC, Lin FY, Wang ST, Lin CY, et al.

(5) Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemiaLeukemiaApril 1, 2023Larrue C, Mouche S, Lin S, Simonetta F, Scheidegger NK, Poulain L, Birsen R, Sarry JE, Stegmaier K, Tamburini J.

(6) Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticlesMolecular Therapy - Methods & Clinical DevelopmentJune 9, 2022Alicia Davis, Kevin V. Morris, Galina Shevchenko(Stemcell Technologies 07980). CD34+ cell culture For the primary bone marrow CD34+ human progenitor cells (ATCC PCS-800-012), cells were maintained using the StemSpan Leukemic Cell Culture Kit (Stemcell Technologies 09720) according

(7) Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stressNature cancerFebruary 1, 2022Bonagas N, Gustafsson NMS, Henriksson M, Marttila P, Gustafsson R, Wiita E, Borhade S, Green AC, Vallin KSA, Sarno A, et al.Normal, human, primary bone marrow CD34+ cells (American Type Culture Collection (ATCC), catalog no. PCS-800-012) were cultured in SFEM II medium (Stemcell) supplemented with a cytokine cocktail containing 20 ng ml−1

(8) Syndecan-4 functionalization of tissue regeneration scaffolds improves interaction with endothelial progenitor cellsRegenerative BiomaterialsNovember 29, 2021Harleigh Warner, Yidi Wu, William D Wagneradded) and plotted against the heparin concentration. Cell culture Human Bone Marrow Derived cells (PCS-800-012) were purchased from ATCC. Cells were characterized by flow cytometry to be positive for CD34 and CD45.

(9) Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase InhibitorsCancers (Basel)November 4, 2021Hyeok-Jae Jang et al.(CD34+/CML) at the time of initial CML diagnosis were processed. Primary BM CD34+ cells (CD34+/Norm; PCS-800-012) were obtained from the ATCC. The cells were washed and resuspended in SFEM II at a density of 1 × 106

(10) A neurovascular-unit-on-a-chip for the evaluation of the restorative potential of stem cell therapies for ischaemic strokeNature biomedical engineeringAugust 1, 2021Lyu Z, Park J, Kim KM, Jin HJ, Wu H, Rajadas J, Kim DH, Steinberg GK, Lee W.as the hiPSC-derived NSC. Human hematopoietic stem cells (hHSC) were purchased from ATCC (Cat. No.: PCS-800-012) and used directly for experiments without subculturing. Medium was changed every 2–3 days. Cells were

(11) MiCas9 increases large size gene knock-in rates and reduces undesirable on-target and off-target indel editsNature communicationsNovember 27, 2020Ma L, Ruan J, Song J, Wen L, Yang D, Zhao J, Xia X, Chen YE, Zhang J, Xu J.11995-065, ThermoFisher Scientific) supplemented with 10% fetal bovine serum. Human CD34+ HSCs (Cat# PCS-800-012, ATCC) were cultured in Steriflip-filtered StemSpan SFEM II medium (Cat# 09655, StemCell Technologies)

(12) A Computational Simulation Technology for Specific Counting of Perinatal and Postnatal Human Tissue Stem Cells for Transplantation MedicineOBM TransplantationAugust 28, 2020Renly Dutton, AlphaSTAR Corporation, Long Beach, CA, 90804, USA, Frank Abdi, Levon Minnetyan, James L. Sherley, AlphaSTAR Corporation, Long Beach, CA, 90804, USA, AlphaSTAR Corporation, Long Beach, CA, 90804, USA, Asymmetrex, LLC, P.O. Box 301179, Boston, MA, 02130-1822, USA(Boston, MA, USA; #EJS002). CD34+-selected normal human bone marrow cells were purchased from the ATCC (#PCS-800-012). CD34+-selected human umbilical cord blood cells were purchased from STEMCELL Technologies, Inc. (Cat#

(13) Diseño y predicción de promotores específicos de neuroblastomaDianasSeptember 30, 2019Jorge Mínguez Martínez, Raúl Torres Ruíz, Sandra Rodríguez Peralesdistintos tipos de tumores y células primarias normales: A673 (ATCC CRL-1598, sarcoma de Ewing), CD34 (ATCC PCS-800-012, hematopoyéticas), O7N217 (glándula suprarrenal, cedidas por el Grupo de Cáncer Endocrino del Centro

(14) Mesenchymal Stem Cells Attract Endothelial Progenitor Cells via a Positive Feedback Loop between CXCR2 and CXCR4Stem cells internationalJanuary 1, 2019Tan Y, Shu L, Xu P, Bai S.endothelial progenitor cells (hEPCs) were purchased from the American Type Culture Collection (ATCC number PCS-800-012). Cells were cultured in an Endothelial Cell Medium (ECM; ScienCell Research Laboratories, Canada) containing

(15) NFκB regulates p21 expression and controls DNA damage-induced leukemic differentiationOncogeneJuly 1, 2018Nicolae CM, O'Connor MJ, Constantin D, Moldovan GL.

(16) Mesenchymal stem cells promote endothelial progenitor cell migration, vascularization, and bone repair in tissue-engineered constructs via activating CXCR2-Src-PKL/Vav2-Rac1FASEB journal : official publication of the Federation of American Societies for Experimental BiologyApril 1, 2018Li Z, Yang A, Yin X, Dong S, Luo F, Dou C, Lan X, Xie Z, Hou T, Xu J, et al.

Be the First to Write a Review!

Primary Bone Marrow CD34+ Cells, Normal, Human from ATCC

Description

ATCC

Citations (16)

Reviews

Primary Bone Marrow CD34+ Cells, Normal, Human from ATCC

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map